SCHEMBL1010137

SCHEMBL1010137

OCC[C@@H]1CCCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL214440 1.00
SCHEMBL891139 1.00
Hydrochloric Acid SCHEMBL3429783 0.98 FDPS (0.44)
SCHEMBL4654415 0.98 CYP2D6 (0.48)
Hydrochloric Acid SCHEMBL5682887 0.98 FDPS (0.44)
Hydrochloric Acid SCHEMBL3429292 0.98 FDPS (0.44)
Hydrochloric Acid SCHEMBL9739532 0.96 CYP2D6 (0.47)
Piperazine SCHEMBL28112800 0.94 FDPS (0.42)
SCHEMBL1190914 0.93
SCHEMBL2908604 0.93 FDPS (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051963-B1 PROCESS FOR RESOLVING CHIRAL PIPERIDINE ALCOHOL AND PROCESS FOR SYNTHESIS OF PYRAZOLO [1,5-A]PYRIMIDINE DERIVATIVES USING SAME SCHERING CORP (US) 2012-05-16 EP claimed
US-7786306-B2 Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo[1,5-a] pyrimidine derivatives using same SCHERING CORPORATION (US) 2010-08-31 US claimed
EP-2051963-A1 PROCESS FOR RESOLVING CHIRAL PIPERIDINE ALCOHOL AND PROCESS FOR SYNTHESIS OF PYRAZOLO [1,5-A]PYRIMIDINE DERIVATIVES USING SAME SCHERING CORPORATION (US) 2009-04-29 EP claimed
US-20080051579-A1 Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo[1,5-a] pyrimidine derivatives using same MERCK SHARP & DOHME LLC 2008-02-28 US claimed
WO-2008021509-A1 PROCESS FOR RESOLVING CHIRAL PIPERIDINE ALCOHOL AND PROCESS FOR SYNTHESIS OF PYRAZOLO [1,5-A] PYRIMIDINE DERIVATIVES USING SAME SCHERING CORPORATION (US) 2008-02-21 WO claimed
US-RE50776-E1 Inhibitors of cyclin-dependent kinases DANA-FARBER CANCER INSTITUTE, INC. (US) 2026-02-03 US disclosed
WO-2025067540-A1 PYRAZOLOTRIAZINE AND PYRAZOLOPYRIMIDINE DERIVATIVES, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE THEREOF 中国科学院上海药物研究所 2025-04-03 WO disclosed
US-12098154-B2 Inhibitors of cyclin-dependent kinases DANA-FARBER CANCER INSTITUTE, INC. (US) 2024-09-24 US disclosed
CN-118480029-A 2-Aminopyrimidine compound or salt thereof, and preparation method and application thereof 励缔(杭州)医药科技有限公司 2024-08-13 CN disclosed
US-20240246995-A1 PYRIMIDINONE DERIVATIVE AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE Shanghai Simr Biotechnology Co., Ltd. (CN) 2024-07-25 US disclosed
US-20240166693-A1 METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPY 1 Design Therapeutics, Inc. 2024-05-23 US disclosed
US-11945822-B2 Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase QURIENT CO., LTD. (KR) 2024-04-02 US disclosed
US-20040209878-A1 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors SCHERING CORPORATION AND PHARMACOPEIA, INC. 2004-10-21 US disclosed
CN-1146543-C Serine protease inhibitor ��˹��ŵ�� 2004-04-21 CN disclosed
CN-1348444-A Serine protease inhibitor AKZO NOBEL NV (NL) 2002-05-08 CN disclosed
EP-1123280-A1 SERINE PROTEASE INHIBITOR Akzo Nobel N.V. (NL) 2001-08-16 EP disclosed
WO-2000024718-A1 SERINE PROTEASE INHIBITOR AKZO NOBEL N.V. (NL) 2000-05-04 WO disclosed
US-5917034-A Antithrombotic n-amidinopiperidine and benzamidine derivatives PFIZER INC. (US) 1999-06-29 US disclosed
EP-0858458-A1 ANTITHROMBOTIC N-AMIDINOPIPERIDINE AND BENZAMIDINE DERIVATIVES Pfizer Limited (GB) 1998-08-19 EP disclosed
WO-1997016444-A1 ANTITHROMBOTIC N-AMIDINOPIPERIDINE AND BENZAMIDINE DERIVATIVES PFIZER LIMITED (GB) 1997-05-09 WO disclosed